Literature DB >> 19502384

Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.

Asta Jurkuvenaite1, Lan Chen, Rafal Bartoszewski, Rebecca Goldstein, Zsuzsa Bebok, Sadis Matalon, James F Collawn.   

Abstract

The most common mutation in the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene, Delta F508, results in the production of a misfolded protein that is rapidly degraded. The mutant protein is temperature sensitive, and prior studies indicate that the low-temperature-rescued channel is poorly responsive to physiological stimuli, and is rapidly degraded from the cell surface at 37 degrees C. In the present studies, we tested the effect of a recently characterized pharmacological corrector, 2-(5-chloro-2-methoxy-phenylamino)-4'-methyl-[4,5'bithiazolyl-2'-yl]-phenyl-methanone (corr-4a), on cell surface stability and function of the low-temperature-rescued Delta F508 CFTR. We demonstrate that corr-4a significantly enhanced the protein stability of rescued Delta F508 CFTR for up to 12 hours at 37 degrees C (P < 0.05). Using firefly luciferase-based reporters to investigate the mechanisms by which low temperature and corr-4a enhance rescue, we found that low-temperature treatment inhibited proteasomal function, whereas corr-4a treatment inhibited the E1-E3 ubiquitination pathway. Ussing chamber studies indicated that corr-4a increased the cAMP-mediated Delta F508 CFTR response by 61% at 6 hours (P < 0.05), but not at later time points. However, addition of the CFTR channel activator, 4-methyl-2-(5-phenyl-1H-pyrazol-3-yl)-phenol, significantly augmented cAMP-stimulated currents, revealing that the biochemically detectable cell surface Delta F508 CFTR could be stimulated under the right conditions. Our studies demonstrate that stabilizing rescued Delta F508 CFTR was not sufficient to obtain maximal Delta F508 CFTR function in airway epithelial cells. These results strongly support the idea that maximal correction of Delta F508 CFTR requires a chemical corrector that: (1) promotes folding and exit from the endoplasmic reticulum; (2) enhances surface stability; and (3) improves channel activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502384      PMCID: PMC2830406          DOI: 10.1165/rcmb.2008-0434OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  51 in total

1.  Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.

Authors:  Ying Wang; M Claire Bartlett; Tip W Loo; David M Clarke
Journal:  Mol Pharmacol       Date:  2006-04-19       Impact factor: 4.436

2.  Correctors of protein trafficking defects identified by a novel high-throughput screening assay.

Authors:  Graeme W Carlile; Renaud Robert; Donglei Zhang; Katrina A Teske; Yishan Luo; John W Hanrahan; David Y Thomas
Journal:  Chembiochem       Date:  2007-06-18       Impact factor: 3.164

3.  A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator.

Authors:  Marina S Gelman; Elisa S Kannegaard; Ron R Kopito
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

4.  Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells.

Authors:  Marie E Egan; Judith Glöckner-Pagel; Catherine Ambrose; Paula A Cahill; Lamiko Pappoe; Naomi Balamuth; Edward Cho; Susan Canny; Carsten A Wagner; John Geibel; Michael J Caplan
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

5.  Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression.

Authors:  András Rab; Rafal Bartoszewski; Asta Jurkuvenaite; John Wakefield; James F Collawn; Zsuzsa Bebok
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-20       Impact factor: 4.249

Review 6.  What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.

Authors:  Marijke Proesmans; François Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2008-04-04       Impact factor: 3.183

7.  Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking.

Authors:  Xiaodong Wang; Atanas V Koulov; Wendy A Kellner; John R Riordan; William E Balch
Journal:  Traffic       Date:  2008-07-30       Impact factor: 6.215

8.  Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.

Authors:  Jesse M Hunter; Mathieu Lesort; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

9.  The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response.

Authors:  Rafal Bartoszewski; András Rab; George Twitty; Lauren Stevenson; James Fortenberry; Arkadiusz Piotrowski; Jan P Dumanski; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2008-03-04       Impact factor: 5.157

10.  Enhanced cell-surface stability of rescued DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones.

Authors:  Karoly Varga; Rebecca F Goldstein; Asta Jurkuvenaite; Lan Chen; Sadis Matalon; Eric J Sorscher; Zsuzsa Bebok; James F Collawn
Journal:  Biochem J       Date:  2008-03-15       Impact factor: 3.857

View more
  30 in total

1.  Cystic fibrosis transmembrane conductance regulator interacts with multiple immunoglobulin domains of filamin A.

Authors:  Martin P Playford; Elisa Nurminen; Olli T Pentikäinen; Sharon L Milgram; John H Hartwig; Thomas P Stossel; Fumihiko Nakamura
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

Review 2.  Rescuing ΔF508 CFTR with trimethylangelicin, a dual-acting corrector and potentiator.

Authors:  James F Collawn; Lianwu Fu; Rafal Bartoszewski; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-25       Impact factor: 5.464

Review 3.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

4.  A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein.

Authors:  Rafal A Bartoszewski; Michael Jablonsky; Sylwia Bartoszewska; Lauren Stevenson; Qun Dai; John Kappes; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

5.  Cyanoquinolines with independent corrector and potentiator activities restore ΔPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis.

Authors:  Puay-Wah Phuan; Baoxue Yang; John M Knapp; Alex B Wood; Gergely L Lukacs; Mark J Kurth; A S Verkman
Journal:  Mol Pharmacol       Date:  2011-07-05       Impact factor: 4.436

Review 6.  CFTR: folding, misfolding and correcting the ΔF508 conformational defect.

Authors:  Gergely L Lukacs; A S Verkman
Journal:  Trends Mol Med       Date:  2011-12-03       Impact factor: 11.951

7.  Functional and pharmacological induced structural changes of the cystic fibrosis transmembrane conductance regulator in the membrane solved using SAXS.

Authors:  Debora Baroni; Olga Zegarra-Moran; Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2014-10-02       Impact factor: 9.261

8.  Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Alessandro Luciani; Valeria Rachela Villella; Speranza Esposito; Manuela Gavina; Ilaria Russo; Marco Silano; Stefano Guido; Massimo Pettoello-Mantovani; Rosa Carnuccio; Bob Scholte; Antonella De Matteis; Maria Chiara Maiuri; Valeria Raia; Alberto Luini; Guido Kroemer; Luigi Maiuri
Journal:  Autophagy       Date:  2012-08-09       Impact factor: 16.016

9.  Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry.

Authors:  Chandrima Sinha; Weiqiang Zhang; Chang Suk Moon; Marcelo Actis; Sunitha Yarlagadda; Kavisha Arora; Koryse Woodroofe; John P Clancy; Songbai Lin; Assem G Ziady; Raymond Frizzell; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Chembiochem       Date:  2015-08-11       Impact factor: 3.164

10.  A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Lianwu Fu; Sadis Matalon; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2015-09-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.